The role of carcinoembryonic antigen monitoring in management of colorectal cancer.

M. F. Mulcahy*, A. B. Benson

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations

Abstract

Carcinoembryonic antigen (CEA) is an important tool in the management of colorectal cancer. Its use as a prognostic indicator in resectable disease remains controversial but may be improved with molecular detection of the antigen. In monitoring patients after resection, CEA can be the first sign of a potentially curable recurrence. It can also be useful in assessing tumor response in patients being treated for metastases without easily measurable disease. CEA alone cannot dictate the type or duration of treatment but may be used in addition to standard monitoring tests.

Original languageEnglish (US)
Pages (from-to)168-172
Number of pages5
JournalCurrent oncology reports
Volume1
Issue number2
DOIs
StatePublished - 1999

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'The role of carcinoembryonic antigen monitoring in management of colorectal cancer.'. Together they form a unique fingerprint.

Cite this